|
|
Volumn 468, Issue 7326, 2010, Pages 878-
|
|
Slim spoils for obesity drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
AMFEBUTAMONE PLUS ZONISAMIDE;
ANTIOBESITY AGENT;
APPETITE STIMULANT;
EMPATIC;
GLUCAGON LIKE PEPTIDE 1;
LIRAGLUTIDE;
LORCASERIN;
NALTREXONE;
PHENTERMINE;
PRAMLINTIDE;
TESOFENSINE;
TETRAHYDROLIPSTATIN;
TOPIRAMATE;
UNCLASSIFIED DRUG;
VELNEPERIT;
ZONISAMIDE;
ALCOHOLISM;
ANOREXIA;
BIRTH DEFECT;
CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG COST;
DRUG MARKETING;
EPIDEMIC;
EPILEPSY;
FOOD AND DRUG ADMINISTRATION;
HEALTH INSURANCE;
HUMAN;
INSULIN SENSITIVITY;
MEMORY DISORDER;
NOTE;
OBESITY;
PRIORITY JOURNAL;
STOMACH EMPTYING;
WEIGHT REDUCTION;
ANTI-OBESITY AGENTS;
APPETITE;
APPETITE DEPRESSANTS;
BODY WEIGHT;
CANNABINOIDS;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
LACTONES;
OBESITY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 78650376414
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/468878a Document Type: Note |
|
Times cited : (13)
|
|
References (0)
|
